Related by context. All words. (Click for frequent words.) 74 Angiotensin Converting Enzyme 74 PEGylated Fab fragment 73 selective antagonist 73 Initiate Phase 73 cromolyn sodium 73 Mg Uk 72 Orally administered 72 Mg Usa 72 sodium glucose cotransporter 71 ergot derivatives 71 vapreotide acetate 71 topical gel formulation 71 selective A2A adenosine receptor 71 cetuximab Erbitux R 71 PEGylated anti 71 PPAR gamma agonist 71 2A receptor agonist 71 MKC# MT 71 PRN FDA Approves 71 Ecallantide 71 topically administered 70 selective modulator 70 reuptake inhibitor 70 norepinephrine reuptake inhibitor 70 Aflibercept 70 receptor tyrosine kinase inhibitor 70 dasatinib Sprycel ® 70 receptor blocker 70 Randomized Phase 70 adalimumab Humira 70 generation purine nucleoside 70 itraconazole Sporanox 70 Recombinant Human 70 Azacitidine 70 diarrhea predominant irritable 70 orally administered inhibitor 70 intranasal formulation 70 Ziprasidone 70 peripherally acting 70 Parathyroid Hormone 70 Xyfid TM 70 non nucleoside inhibitor 70 prucalopride 69 Refractory Hodgkin Lymphoma 69 humanized interleukin 6 69 Meets Primary Endpoint 69 Lubiprostone 69 dihydrochloride 69 antibody MAb 69 INSPIRE Trial Phase III 69 thalidomide Thalomid 69 albiglutide 69 Inhalation Aerosol 69 Pharmacokinetics PK 69 cortisol synthesis 69 Dose Ranging Study 69 beta 1a 69 SPRYCEL ® 69 peripherally restricted 69 Monopril 69 treatment naive genotype 69 Intravitreal 69 Successfully Completes Phase 69 aripiprazole Abilify 69 novel VDA molecule 69 AAG geldanamycin analog 69 Myelodysplastic Syndrome MDS 69 ADP receptor antagonist 69 Safinamide 69 ALN HPN 69 oral dual endothelin 69 myelodysplastic myeloproliferative diseases 69 Zorbtive TM 69 phase III isavuconazole 69 Sapacitabine 69 NMDA antagonist 68 small molecule Hedgehog 68 Study Evaluating 68 histone deacetylase HDAC inhibitor 68 Interferon alfa 68 MAGE A3 ASCI 68 Initiates Phase 68 approved incretin mimetic 68 salmeterol fluticasone 68 injected subcutaneously 68 Eltrombopag 68 protein tyrosine phosphatase 1B 68 pharmacologically active isomer 68 Bosutinib 68 AVAPRO 68 insulin glulisine 68 Investigational Treatment 68 Temsirolimus 68 Completes Patient Enrollment 68 Phase 2b Clinical Trial 68 Receptor Antagonists 68 GW# [003] 68 small molecule tyrosine 68 brivanib 68 JZP 68 cis retinoic acid 68 Interferon beta 1b 68 2 methoxyestradiol 68 basiliximab 68 balsalazide disodium Capsules 68 oral dihydropyrimidine dehydrogenase DPD 68 prokinetic agent 68 visilizumab 68 inflammatory PDE 68 Investigational Oral 68 quetiapine Seroquel 68 Initiated Phase 68 pan histone deacetylase 68 acarbose 68 humanized therapeutic 68 Degarelix 68 vinorelbine tartrate 68 somatostatin analog 68 administered concomitantly 68 agonistic human 68 5 Fluorouracil 68 Angiotensin 68 Pegylated Liposomal Doxorubicin 68 Dementia Related Psychosis 68 CYT# potent vascular disrupting 68 Methylnaltrexone 68 Janus kinase 68 Inhalation Solution 68 humanized monoclonal 68 lexidronam injection 68 methylnaltrexone bromide 68 Pemetrexed 68 immunomodulatory therapy 68 PDE4 inhibitor 68 prescribed proton pump 68 Initiates Enrollment 68 Panzem R 68 Vidaza azacitidine 68 IAP inhibitor 68 Prolongs Survival 68 CYP#A# CYP#D# 68 reversible inhibitor 68 abacavir Ziagen 68 toenail onychomycosis 68 fumarate 68 5 HT2A serotonin 68 investigational humanized monoclonal antibody 67 Drug Candidate 67 combines bupropion 67 PNP inhibitor 67 ziprasidone Geodon 67 Ovitrelle R Serostim 67 alfa 2a 67 Teriflunomide 67 Hycamtin ® 67 erlotinib Tarceva ® 67 Decitabine 67 PEGINTRON TM 67 Initiates Phase II 67 calcineurin inhibitor 67 Adjunctive Therapy 67 docetaxel Taxotere ® 67 dexamethasone Decadron 67 5 HT2A inverse 67 Tocilizumab 67 valproate sodium 67 sunitinib Sutent ® 67 R Saizen R 67 Irinotecan 67 Pathway Inhibitor 67 receptor inhibiting monoclonal 67 Patients Treated With 67 biologic DMARD 67 Acute Exacerbations 67 Initiate Clinical Trial 67 RhuDex TM 67 Peginterferon 67 Ropinirole 67 reslizumab 67 octreotide acetate 67 polycythemia vera essential thrombocythemia 67 LymphoStat B belimumab 67 highly selective endothelin 67 relapsed MM 67 Sodium oxybate 67 irreversible inhibitor 67 Testosterone MDTS R 67 Receives Orphan Drug Designation 67 Denufosol 67 FUSILEV enhances 67 Hydrochlorothiazide Tablets 67 Levoleucovorin 67 hyaluronidase enzyme 67 small molecule thrombopoietin 67 Ganciclovir 67 mertansine 67 injectable formulation 67 anti CTLA 67 COLAZAL R 67 trospium chloride 67 Complicated Skin 67 Ofatumumab 67 Phase IIb Trial 67 ritonavir boosted 67 MKC# 67 #HT# 67 Calcitonin 67 Hsp# Inhibitor 67 acetonide FA 67 ® lenalidomide 67 Oral Fingolimod 67 essential thrombocythemia ET 67 5 lipoxygenase inhibitor 67 sodium thiosulfate STS 67 Cimzia ® certolizumab pegol 67 dasatinib Sprycel 67 targeted radiotherapeutic 67 pralatrexate injection folate analogue 67 ZOLINZA 67 mGluR2 positive 67 Hormone Refractory Prostate Cancer 67 treat chronic sinusitis 67 DDP# 67 5 HT3 antagonist 67 targeted antifolate 67 TLK# 67 Ondansetron Injection USP 67 JAK Inhibitor 67 potassium binder 67 Glatiramer Acetate 67 vesicular monoamine transporter 67 Pivotal Phase 67 non splenectomized 67 novel histone deacetylase 67 inverse agonist 67 Aliskiren 67 Kuvan sapropterin dihydrochloride 67 headache abdominal pain 67 HCV RNA polymerase 67 rivastigmine Exelon 67 Seliciclib 67 RELOVAIR ™ 67 Ozarelix 67 factor TNF 67 DEB# 67 Nebulized 67 guanfacine extended release 67 Metastatic Melanoma 67 oral nucleoside analogue 67 BCR ABL inhibitor 67 developing Bicifadine serotonin 67 Replacement Therapy 67 EMSAM 67 verteporfin 67 pregabalin Lyrica 67 pouchitis 67 Peginterferon alfa 2b 67 Vascular Disrupting Agent 67 Capecitabine 67 Diabetic Nephropathy 67 etanercept Enbrel 67 Enzastaurin 67 Thiazolidinediones 67 orally inhaled 67 MOVIPREP R 67 Files IND 66 Receptor Agonist 66 Saxagliptin 66 Phase 2b Study 66 Pivotal Phase III 66 Randomized Double blind 66 RTP #i 66 SAR# [002] 66 microtubule inhibitor 66 highly selective inhibitor 66 sulindac 66 receptor partial agonist 66 Romiplostim 66 intravenously administered 66 LAB CGRP 66 Multiple Ascending Dose 66 gets USFDA nod 66 Pafuramidine 66 RhuDex R 66 Elvitegravir 66 XL# anticancer compounds 66 Camptosar ® 66 IgG1 monoclonal antibody 66 Initiates Clinical 66 Novel Oral 66 Requip XL 66 rosiglitazone maleate 66 Initiates Clinical Trial 66 reduce serum phosphate 66 Febuxostat 66 Phase 2b Trial 66 Simulect 66 8mg/kg 66 mGluR5 negative 66 lamotrigine Lamictal 66 Relapsing Multiple Sclerosis 66 Carbidopa 66 peritumoral brain edema 66 Traficet EN 66 Aurora Kinase 66 oral prodrug 66 Phase IIA 66 receiving INTRON 66 Pegloticase 66 hypereosinophilic syndrome 66 non nucleoside HCV 66 Launches Generic Version 66 Luteinizing Hormone Releasing Hormone 66 Adjunctive 66 interferon gamma 1b 66 Kamada AAT 66 Roflumilast 66 orally disintegrating 66 Pramlintide 66 baminercept 66 imipramine Tofranil 66 Soriatane R 66 brand ciclesonide HFA 66 Fluorouracil 66 NS5B polymerase 66 Transdermal Patch 66 Phase IIa Clinical Trial 66 HCD# [002] 66 sorafenib Nexavar 66 Divalproex Sodium 66 haloperidol Haldol 66 aurora kinase 66 administered intranasally 66 #mg #mg #mg [003] 66 oropharyngeal candidiasis OPC 66 lidocaine patch 66 HMG CoA reductase inhibitors 66 selective adenosine 66 Testosterone MDTS ® 66 pioglitazone hydrochloride 66 Mylan Receives Approval 66 retinal vein occlusion induced 66 Monoclonal Antibody 66 5HT 66 MKC# MKC# PP 66 adenosine injection 66 LymphoStat B TM 66 Tarceva TM 66 fluvastatin 66 6R BH4 66 rufinamide 66 potential vanilloid 66 tazobactam 66 pioglitazone HCl 66 markets COLAZAL 66 severe oral mucositis 66 formerly LymphoStat B 66 Atrasentan 66 acyclovir Lauriad R 66 Tasigna nilotinib 66 anti muscarinic 66 polycythemia vera PV 66 orally administered synthetic retinoid 66 mg q#h 66 5 hydroxytryptamine 66 comparator arm 66 hydrochloride tablets 66 oral rivaroxaban 66 zolmitriptan 66 Adenoscan R 66 Itraconazole 66 Fluticasone 66 Neulasta ® 66 systemic juvenile idiopathic 66 Medoxomil 66 dyskinesia PD LID 66 metformin HCl 66 lansoprazole Prevacid 66 muscarinic receptor agonist 66 Navelbine ® 66 receptor antagonism 66 Phase 2a Clinical Trial 66 Receptor Antagonist 66 refractory chronic lymphocytic 66 AKT inhibitor 66 Begins Dosing 66 Telithromycin 66 Sustiva efavirenz 66 Seroquel quetiapine fumarate 66 Catapres 66 clomipramine 66 Dasatinib 66 Presents Positive 66 headache nasopharyngitis 66 arsenic trioxide injection 66 Janus Kinase 66 clotrimazole 66 Commences Phase 66 sitaxsentan 66 lintuzumab SGN 66 Posaconazole 66 PrevOnco 66 CLL SLL 66 receptor antagonists 66 lenalidomide Revlimid R 66 Clinical Trial Evaluating 66 doxazosin 66 Parnate 66 TÎ ² 4 66 candidate deforolimus 66 Kinase Inhibitor 66 levetiracetam Keppra 66 somatostatin analogue 66 adecatumumab MT# 66 selective inhibitor 66 piroxicam 66 TNF Tumor Necrosis Factor 66 Namenda XR 66 Loceryl ® 66 #mg/#mg 66 TO AVOID PREGNANCY WHILE 66 terfenadine 66 plasmid encoding 66 alpha antagonist 66 Demonstrates Significant 66 papillary renal cell carcinoma 66 selective androgen receptor modulator 66 Atripla combines 66 zonisamide SR 66 Zileuton 66 CTAP# Capsules 66 receptor inhibitor 66 enkephalin 66 Randomized Double Blind 66 alefacept 66 maleate 66 Xeloda ® 66 virus HCV protease inhibitor 66 Treanda bendamustine 66 Tanespimycin 66 liposomal formulation 66 PENTASA 66 divalproex sodium 66 EOquin TM phase 66 nitrofurantoin 66 docetaxel Taxotere R 66 xanthine oxidase inhibitor 66 Tyrosine Kinase Inhibitor 66 1mg 2mg 66 Factor Receptor 66 ropinirole Requip 66 Amrubicin 66 induce orthostatic hypotension 66 Renal Impairment 65 receptor modulators 65 sertraline Zoloft 65 aminolevulinic acid 65 orally disintegrating tablets 65 estramustine 65 Pimavanserin 65 ABILIFY ® 65 Bezielle 65 REMINYL ® 65 SinuNase TM 65 Protease Inhibitor 65 Vitrasert R 65 KSP inhibitor 65 chimeric monoclonal antibody 65 cyclobenzaprine 65 proteasome inhibitor 65 esomeprazole Nexium 65 Fondaparinux 65 ß blockers 65 Trial Evaluating 65 cutaneous T 65 Eszopiclone 65 Infusion Reactions Severe 65 Intravenous immunoglobulin 65 MTP inhibitor 65 Dapagliflozin 65 Commence Phase 65 Belerofon 65 ORENCIA ® 65 MET VEGFR2 65 Sudhir Agrawal D.Phil 65 Peptide YY 65 ceftazidime 65 oral levofloxacin 65 gefitinib Iressa 65 ULTRASE 65 sapropterin dihydrochloride Phase 65 CDK inhibitor 65 Double Blind Randomized 65 zileuton 65 demonstrated antitumor activity 65 RhuDex ® 65 mesylate 65 hypoxia activated prodrug 65 Submits NDA 65 R lenalidomide 65 Silodosin 65 humanised monoclonal antibody 65 Remicade infliximab 65 acetylcholinesterase inhibitor 65 investigational antiplatelet agent 65 TYGACIL 65 Vaprisol 65 HCl Tablets 65 LY# [002] 65 administered subcutaneously 65 including eniluracil ADH 65 alkylating agent 65 Systemic Sclerosis 65 potent topoisomerase II 65 abacavir lamivudine 65 MGd 65 chronic eosinophilic leukemia 65 p# MAP kinase inhibitor 65 leukotriene receptor antagonist 65 ethinyl estradiol tablets 65 paroxetine sertraline 65 Raptiva R 65 Galantamine 65 induced macular edema 65 inhalation aerosol 65 mometasone furoate 65 Glypromate 65 iobenguane 65 Presents Preclinical Data 65 oral Janus kinase 65 Granulocyte Colony Stimulating Factor 65 investigational protease inhibitor 65 treat benign prostatic 65 sunitinib Sutent 65 Shows Statistically Significant 65 Bicalutamide 65 NanoEmulsion 65 GABITRIL 65 containing granisetron 65 induced mucositis 65 norepinephrine reuptake inhibitor SNRI 65 Chemokine Receptor 65 CTAP# Injection 65 IL# PE#QQR 65 Pruvel TM 65 Ribavirin causes 65 prochlorperazine 65 Prodrug 65 COLAZAL ® 65 RAPTIVA 65 Maribavir 65 icatibant 65 Peginterferon Alfa 2a 65 heFH 65 benzoic acid hyoscyamine sulfate 65 Atomoxetine 65 Tezampanel 65 Anti VEGF 65 estrogen receptor antagonist 65 serotonin norepinephrine reuptake inhibitor 65 FOLOTYN ® 65 recurrent glioblastoma multiforme 65 budesonide inhalation suspension 65 CIMZIA TM 65 phase IIb study 65 RezularTM 65 Belimumab 65 dihydrofolate reductase 65 Vfend 65 metformin hydrochloride 65 HCV NS5B polymerase 65 selective estrogen receptor modulator 65 INCB# [003] 65 Suppl. 65 eosinophilic asthma 65 Budesonide 65 Luramist TM 65 Soft Tissue Sarcoma 65 Parathyroid hormone 65 include Phenoptin TM 65 Linagliptin 65 topoisomerase II inhibitor 65 alendronate Fosamax 65 multi kinase inhibitor 65 Migranal 65 ethambutol 65 Achieves Primary Endpoint 65 octreotide implant 65 Liprotamase 65 Edoxaban 65 Initiates Phase III 65 Aldara ® 65 fluvastatin Lescol 65 UCB Keppra 65 hyperphenylalaninemia HPA due 65 Ophena TM 65 LUNESTA ® 65 piperacillin tazobactam 65 Submits Response 65 Investigational Compound 65 ganciclovir 65 CYT# QbG# 65 Antitumor Activity 65 Extended Release Tablets 65 uricase 65 drotrecogin alfa activated 65 Abilify aripiprazole 65 either acutely decompensated 65 Darusentan 65 neutropenia dehydration dyspnea 65 familial amyloidotic polyneuropathy FAP 65 Phase III Clinical Trial 65 phenytoin Dilantin 65 CIMZIA ™ 65 Naive Patients 65 MetroGel 65 inhaled corticosteroid ICS 65 denileukin diftitox 65 immune globulin intravenous 65 anti secretory 65 clozapine Clozaril 65 QNEXA ® 65 post herpetic neuralgia PHN 65 Tipranavir 65 Dacogen decitabine 65 Sprycel dasatinib 65 partial agonist 65 Copegus ribavirin 65 PKC# 65 delta gamma agonist 65 inhibitor COX 65 timolol maleate 65 cinacalcet 65 fosbretabulin 65 orally inhaled migraine 65 candesartan cilexetil 65 Fludara ® 65 glucuronide 65 Is Well Tolerated 65 Reminyl galantamine 65 RhuDex 65 PEG IFN 65 5alpha reductase 65 evaluating tivozanib 65 desvenlafaxine succinate 65 sorafenib tablets 65 Vandetanib 65 soluble tumor necrosis 65 Metformin HCl 65 teriflunomide 65 Personalized Immunotherapy 65 refractory NSCLC 65 #mg/day [002] 65 infliximab monotherapy 65 dual orexin receptor 65 Completes Enrollment 65 rabeprazole 65 Oxybutynin 65 cyclin dependent kinase inhibitor 65 Mestinon 65 benign prostatic hypertrophy BPH 65 PROCTOCORT R 65 nicardipine 65 multicenter Phase III 65 chronic idiopathic thrombocytopenic purpura 65 XL# XL# 65 IMiDs ® 65 venlafaxine Effexor 65 HDAC Inhibitor 65 selective agonist 65 Orally Active 65 VEGFR2 inhibitor 65 Elitek 65 mitoxantrone plus 65 imatinib Gleevec ® 65 miconazole Lauriad ® 65 EUFLEXXA R 65 trospium 65 trial evaluating PRX# 65 investigational pharmacologically unique 65 Interferon gamma 65 insulin sensitizers 65 Protease Inhibitors 65 anti angiogenic agent 65 Velcade bortezomib 65 Interferon beta 65 bone marrow reticulin deposition 65 Tofacitinib 65 Announces Tentative Approval 65 Primary Hypercholesterolemia 65 allosteric modulator PAM 65 indinavir Crixivan 65 thiazide diuretic 65 Natalizumab 65 Navelbine 65 Empatic ™ 65 Esomeprazole 65 Piperacillin 65 voriconazole 65 HCV SPRINT 65 Amgen Neulasta ® 65 dopamine partial agonist 65 REGN# 65 sufentanil 65 plasma kallikrein inhibitor 65 QD dosing 65 acadesine 65 Diovan Exforge Tekturna Zelnorm 65 Glucagon Like Peptide 65 Crofelemer budesonide foam 65 amphotericin B 65 dopamine D2 65 Central Retinal Vein 65 Trabectedin 65 Soriatane 65 Emtriva emtricitabine 65 refractory gout 64 mu opioid receptor antagonist 64 midstage clinical 64 kidney urologic 64 vWD 64 selective A1 adenosine 64 complement inhibitor eculizumab 64 medoxomil 64 Axid 64 daily subcutaneous injections 64 Pooled Analysis 64 subcutaneously administered 64 Acute Attacks 64 MULTAQ 64 monoamine oxidase inhibitors 64 memantine HCl 64 AFREZZA TM 64 oral JAK1 64 Argatroban 64 weekly subcutaneous injections 64 Etravirine 64 rheumatoid arthritis psoriatic arthritis 64 valsartan Diovan 64 Fluconazole 64 fluticasone furoate 64 Beclomethasone 64 Disease Modifying 64 doxepin HCl 64 opioid induced bowel dysfunction 64 orally bioavailable 64 CorVue ™ 64 relapsing multiple sclerosis 64 Acetate Rectal Suppositories 64 administered intramuscularly 64 Risperidone Oral Solution 64 incretin mimetic 64 atazanavir ritonavir 64 endothelin receptor 64 DP VPA 64 syndrome IBS 64 Fingolimod 64 Phase 2a Trial 64 catheter occlusion 64 ZACTIMA 64 Cytarabine 64 diaper dermatitis complicated 64 Previously Treated 64 Saquinavir 64 Phosphodiesterase 64 oral beclomethasone dipropionate 64 mg Tablets 64 Plaquenil 64 BRINAVESS 64 Tumor Necrosis Factor 64 metastatic malignant 64 Lixivaptan 64 Escitalopram 64 Talabostat 64 nucleotide analog 64 Rhinocort 64 systemically administered 64 Certolizumab pegol 64 tenofovir Viread 64 Interferon alpha 64 Sulfonylurea 64 Treated Patients 64 monocyte chemotactic protein 64 antiepileptics 64 pan HDAC inhibitor 64 metformin sulfonylurea 64 azilsartan medoxomil 64 Squalamine 64 ara C 64 ADL# novel 64 Orally Disintegrating Tablets 64 Phase IIb Clinical Trial 64 Kinoid 64 Cyclobenzaprine 64 Pruvel 64 receiving XGEVA 64 AN# topical anti 64 TKB# 64 Ramelteon 64 Adalimumab 64 sublingual tablets 64 mycophenolate mofetil MMF 64 investigational monoclonal antibody 64 Ranolazine 64 cyclobenzaprine hydrochloride extended 64 corticosteroid dexamethasone 64 selectively inhibits 64 ACE Inhibitors 64 Emtriva Viread 64 anthracycline taxane 64 Daclizumab 64 intravesical instillation 64 boosted protease inhibitor 64 azathioprine monotherapy 64 urate oxidase 64 Demonstrates Efficacy 64 formoterol fumarate 64 fluorouracil leucovorin 64 paroxetine Paxil 64 Iloperidone 64 MEVACOR 64 DepoCyt 64 Bevacizumab 64 rHuPH# recombinant human 64 mGluR5 NAM 64 hypertrichosis occurred 64 Plaque Psoriasis 64 mitoxantrone chemotherapy 64 Lennox Gastaut Syndrome 64 integrin inhibitor 64 IV Busulfex 64 INVEGA ® 64 nucleoside analog 64 PF # [002] 64 neuropathic pain metabolic diseases 64 valsartan amlodipine 64 reverse transcriptase inhibitors 64 thetreatment 64 5 fluorouracil leucovorin 64 Gonal f R 64 metformin XR 64 Gamunex C 64 Second Pivotal Phase 64 Trandolapril 64 beclomethasone dipropionate 64 generation antisense inhibitor 64 Acute Bacterial Sinusitis ABS 64 XP# XP# 64 herpetic keratitis 64 paclitaxel Taxol 64 IND Application 64 ipratropium bromide 64 TNF blocker 64 telomerase therapeutic 64 Gel repository corticotropin injection 64 Omacetaxine 64 Coadministration 64 Extended Release 64 antisense inhibitor 64 angiotensin II receptors 64 Carbidopa Levodopa 64 Fulvestrant 64 intravesical infusion therapy 64 steroid refractory ulcerative 64 brivaracetam 64 SinuNase ™ 64 cytomegalovirus immune globulin 64 Carbamazepine 64 pediatric Crohn disease 64 4 PDE4 enzyme 64 receptor antagonist 64 investigational oral inhibitor 64 Gemzar ® 64 tacrolimus ointment 64 dual PPAR peroxisome 64 alpha interferons 64 Cancidas 64 meropenem 64 Parkinson disease levodopa induced 64 FDA APPROVES 64 Antiviral Therapy 64 5 HT2A 64 Mellaril 64 IMPDH inhibitor 64 Cyclooxygenase 64 Letairis ambrisentan 64 DU #b 64 nitroprusside 64 tolterodine ER 64 gemtuzumab ozogamicin 64 Montelukast 64 gastrin analogue TT 64 CIMZIA TM certolizumab pegol 64 treatment naïve genotype 64 immunomodulatory agents 64 tricyclic antidepressants TCAs 64 selectively inhibited 64 pancreatic enzyme replacement 64 chronic thromboembolic pulmonary 64 CCR5 antagonist 64 lanreotide 64 Vidaza R 64 Factor VIIa 64 Rotigotine 64 Myolimus 64 Vimpat R 64 REPRONEX R menotropins 64 primidone 64 abacavir sulfate lamivudine 64 5 HT6 64 opioid receptor antagonist 64 dipeptidyl peptidase IV 64 HoFH 64 Anturol TM 64 OMP #R# 64 forodesine 64 Darunavir 64 Leucovorin 64 mesalazine 64 hyperplasia BPH 64 buccal spray 64 Placebo Controlled Study 64 Transdermal System 64 Diffuse Large B 64 Excellarate TM 64 pancrelipase 64 gonadotropin releasing hormone GnRH 64 Sugammadex 64 mg/m2 administered 64 topical ophthalmic 64 luteinizing hormone releasing 64 Paxil paroxetine 64 nasal calcitonin product 64 prednisolone acetate 64 nonsteroidal 64 Neulasta R 64 II Clinical Trial 64 LENALIDOMIDE 64 Genentech Rituxan 64 ritonavir boosted atazanavir 64 ACTEMRA TM 64 Presents Preclinical 64 Copegus ® 64 ranitidine Zantac 64 Anthracycline 64 Levetiracetam 64 HepaGam B TM 64 Clinical Trial Results 64 Blinatumomab 64 Bosentan 64 Saizen ® 64 FOLFOX6 64 Desmopressin 64 oral antidiabetic medication 64 omeprazole Prilosec 64 buccal tablets 64 idiopathic thrombocytopenic purpura 64 microgram kg 64 beta2 agonist 64 5 HT4 64 ALGRX 64 JAK2 Inhibitor 64 Newly Diagnosed Multiple Myeloma 64 Relapsed Refractory Multiple Myeloma 64 balsalazide 64 See CLINICAL PHARMACOLOGY 64 Xelox 64 class anticancer quinolone 64 transdermal fentanyl 64 lisdexamfetamine dimesylate 64 R memantine HCl 64 potent CYP#A# inhibitors 64 Angioedema 64 #beta HSD1 64 drug zotarolimus 64 infliximab Remicade 64 danazol 64 zoledronic acid Reclast 64 STELARA TM 64 EVIZON TM 64 polymerase inhibitor 64 Preclinical studies suggest 64 Severe Sepsis 64 losartan potassium 64 Danazol 64 inhibitor SNRI 64 SGPT 64 cell lymphoma CTCL 64 Major Depressive Disorder MDD 64 ug kg 64 Contrave# 64 BRIM2 64 phase IIIb 64 tetracycline antibiotic 64 pegylated interferon alpha 64 Leukine ® 64 Dual Opioid 64 novel topoisomerase 64 G CSFs